Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Relapsed Small Cell Lung Cancer
NCT00009971Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2000
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenretinide in small cell lung cancer (SCLC), sponsored by National Cancer Institute. Started Nov 2000; status: completed.
02
Drugs
fenretinide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00009971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009971.